A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes.
Clin Nutr
; 32(6): 911-7, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-23395257
Palavras-chave
1-alpha-hydroxycholecalciferol; Alfacalcidol; C-Peptide; DID; Diabetes mellitus; FCP; GLM-ANOVA; HLA; HbA1c; Hydroxycholecalciferols; Insulin-secreting cells; Iran; Randomized controlled trial; SMBG; T1DM; Type 1; VDR; daily insulin dosage per body weight; fasting C-peptide; glycated hemoglobin; human leukocyte antigen; multivariate general linear modeling repeated measures ANOVA; self-monitored blood glucose; type 1 diabetes; vitamin D receptor
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limite:
Adolescent
/
Child
/
Female
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article